Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 17Glioblastoma 10Brain Neoplasms 10Gliosarcoma 9Rhabdomyosarcoma 7Osteosarcoma 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Sarcoma, Ewing 5Recurrence 5Leukemia, Myeloid, Acute 5Dendritic Cell Sarcoma, Interdigitating 5Burkitt Lymphoma 5Astrocytoma 5Oligodendroglioma 4Myeloproliferative Disorders 4Myelodysplastic Syndromes 4Multiple Myeloma 4Lymphoma, Non-Hodgkin 4Lymphoma, Mantle-Cell 4Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4Lymphoma 4Leukemia, Lymphocytic, Chronic, B-Cell 4Leukemia 4Hodgkin Disease 4Glioma 4Rhabdoid Tumor 3Primary Myelofibrosis 3Neurofibrosarcoma 3Neuroblastoma 3

Interventions

regorafenib 1pazopanib 1Trabectedin 1Sirolimus 1Radiotherapy 1Radiation 1Pharmacogenomic Testing 1Ifosfamide 1HhAntag691 1Doxorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Chondrosarcoma, Mesenchymal × Sirolimus × Sarcoma × Clear all
NCT02821507 2022-04-20

Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma

Leiden University Medical Center

Phase 2 Completed
70 enrolled
Sarcoma

Liposarcoma, Myxoid, Chondrosarcoma, Mesenchymal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡